Table 4.
Observed event rate (risk) of CHD for different categories of predicted risk assessed using models incorporating or omitting CRP
| Category of predicted riska |
|||||
|---|---|---|---|---|---|
| 0 to <5% | 5 to <10% | 10 to <15% | >15% | Proportion Reclassified (%) | |
| NPHS-II | |||||
| Without CRP | 1119 | 1036 | 199 | 58 | |
| 4.3% | 6.9% | 15.1% | 17.2% | ||
| With CRP | 1184 | 910 | 234 | 84 | 716/2412 |
| 4.2% | 6.6% | 12.8% | 22.6% | (29.7%) | |
| EAS | |||||
| Without CRP | 243 | 359 | 173 | 94 | |
| 4.3% | 7.8% | 21.9% | 22.8% | ||
| With CRP | 333 | 331 | 146 | 109 | 254/919 |
| 4.3% | 8.4% | 20.5% | 26.1% | (27.6%) | |
aRisk is 10-year risk in NPHS-II and EAS. Values in cells are total number of individuals in each predicted risk category, and 10 year event rate (%).